BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kawamori R, Tajima N, Iwamoto Y, Kashiwagi A, Shimamoto K, Kaku K. Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance. Lancet. 2009;373:1607-1614. [PMID: 19395079 DOI: 10.1016/s0140-6736(09)60222-1] [Cited by in Crossref: 208] [Cited by in F6Publishing: 168] [Article Influence: 16.0] [Reference Citation Analysis]
Number Citing Articles
1 Simonetti E, Bosi S, Negri L, Dinelli G. Amylase Trypsin Inhibitors (ATIs) in a Selection of Ancient and Modern Wheat: Effect of Genotype and Growing Environment on Inhibitory Activities. Plants 2022;11:3268. [DOI: 10.3390/plants11233268] [Reference Citation Analysis]
2 Li H, Chang G, Jiang Y, Xu L, Shen L, Gu Z, Lin H, Shi F. System Dynamic Model Simulates the Growth Trend of Diabetes Mellitus in Chinese Population: Implications for Future Urban Public Health Governance. Int J Public Health 2022;67. [DOI: 10.3389/ijph.2022.1605064] [Reference Citation Analysis]
3 Fisher M. Acarbose and Alpha Glucosidase Inhibitors. Diabetes Drug Notes 2022. [DOI: 10.1002/9781119785033.ch11] [Reference Citation Analysis]
4 Fallah Z, Tajbakhsh M, Alikhani M, Larijani B, Faramarzi MA, Hamedifar H, Mohammadi-khanaposhtani M, Mahdavi M. A review on synthesis, mechanism of action, and structure-activity relationships of 1,2,3-triazole-based α-glucosidase inhibitors as promising anti-diabetic agents. Journal of Molecular Structure 2022;1255:132469. [DOI: 10.1016/j.molstruc.2022.132469] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
5 A TR, Basu VR, G S, A S, N SSR. A review on recent trends of diabetes mellitus. J Inn App Pharma Sci 2022. [DOI: 10.37022/jiaps.v7i1.258] [Reference Citation Analysis]
6 Draznin B, Aroda VR, Bakris G, Benson G, Brown FM, Freeman R, Green J, Huang E, Isaacs D, Kahan S, Leon J, Lyons SK, Peters AL, Prahalad P, Reusch JEB, Young-Hyman D, Das S, Kosiborod M; American Diabetes Association Professional Practice Committee., American Diabetes Association Professional Practice Committee:. 3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Medical Care in Diabetes-2022. Diabetes Care 2022;45:S39-45. [PMID: 34964876 DOI: 10.2337/dc22-S003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 14.0] [Reference Citation Analysis]
7 Usman M, Patil PJ, Patil DN, Mehmood A, Shah H, Zahra SM, Ali Z, Nasreen S. Low Glycaemic Index Cereal Grain Functional Foods. Functional Cereals and Cereal Foods 2022. [DOI: 10.1007/978-3-031-05611-6_12] [Reference Citation Analysis]
8 Echouffo-Tcheugui JB, Selvin E. Prediabetes and What It Means: The Epidemiological Evidence. Annu Rev Public Health 2021;42:59-77. [PMID: 33355476 DOI: 10.1146/annurev-publhealth-090419-102644] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 24.0] [Reference Citation Analysis]
9 Sasaki H, Saisho Y, Inaishi J, Itoh H. Revisiting Regulators of Human β-cell Mass to Achieve β-cell-centric Approach Toward Type 2 Diabetes. J Endocr Soc 2021;5:bvab128. [PMID: 34405128 DOI: 10.1210/jendso/bvab128] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Thiruvengadam S, Peter PR. Management of type 2 diabetes without insulin: An update for the PCP. Dis Mon 2021;:101290. [PMID: 34563347 DOI: 10.1016/j.disamonth.2021.101290] [Reference Citation Analysis]
11 Morgunova TB, Glinkina IV, Fadeev VV. Prediabetes: challenges and opportunities. Medicinskij sovet 2021. [DOI: 10.21518/2079-701x-2021-12-220-227] [Reference Citation Analysis]
12 Jonas DE, Crotty K, Yun JDY, Middleton JC, Feltner C, Taylor-Phillips S, Barclay C, Dotson A, Baker C, Balio CP, Voisin CE, Harris RP. Screening for Prediabetes and Type 2 Diabetes: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2021;326:744-60. [PMID: 34427595 DOI: 10.1001/jama.2021.10403] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
13 Antony P, Vijayan R. Bioactive Peptides as Potential Nutraceuticals for Diabetes Therapy: A Comprehensive Review. Int J Mol Sci 2021;22:9059. [PMID: 34445765 DOI: 10.3390/ijms22169059] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
14 Khan IA, Ahmad M, Ashfaq UA, Sultan S, Zaki MEA. Discovery of Amide-Functionalized Benzimidazolium Salts as Potent α-Glucosidase Inhibitors. Molecules 2021;26:4760. [PMID: 34443347 DOI: 10.3390/molecules26164760] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
15 Araki E, Goto A, Kondo T, Noda M, Noto H, Origasa H, Osawa H, Taguchi A, Tanizawa Y, Tobe K, Yoshioka N. Japanese Clinical Practice Guideline for Diabetes 2019. J Diabetes Investig 2020;11:1020-76. [PMID: 33021749 DOI: 10.1111/jdi.13306] [Cited by in Crossref: 80] [Cited by in F6Publishing: 87] [Article Influence: 80.0] [Reference Citation Analysis]
16 Dai M, Xing C, Shi N, Wang S, Wu G, Liao Q, Zhang T, Chen G, Wu W, Guo J, Liu Z. Risk factors for new-onset diabetes mellitus after distal pancreatectomy. BMJ Open Diabetes Res Care 2020;8:e001778. [PMID: 33122295 DOI: 10.1136/bmjdrc-2020-001778] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Zhu C, Niu H, Nie A, Bian M. Bioactivity-guided separation of potential α-glycosidase inhibitor from clerodendranthus spicatus based on HSCCC coupled with molecular docking. Sci Rep 2021;11:6914. [PMID: 33767281 DOI: 10.1038/s41598-021-86379-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
18 Rudrapal M, Hussain N, Egbuna C. Diabetes Mellitus and it Management with Plant-Based Therapy. Dietary Phytochemicals 2021. [DOI: 10.1007/978-3-030-72999-8_7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Naveed A, Farrukh L, Sana MK, Naveed B, Randhawa FA. Pharmacological Primary Prevention of Diabetes Mellitus Type II: A Narrative Review. Cureus 2020;12:e10033. [PMID: 32999773 DOI: 10.7759/cureus.10033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
20 Araki E, Goto A, Kondo T, Noda M, Noto H, Origasa H, Osawa H, Taguchi A, Tanizawa Y, Tobe K, Yoshioka N. Japanese Clinical Practice Guideline for Diabetes 2019. Diabetol Int 2020;11:165-223. [PMID: 32802702 DOI: 10.1007/s13340-020-00439-5] [Cited by in Crossref: 97] [Cited by in F6Publishing: 114] [Article Influence: 48.5] [Reference Citation Analysis]
21 Budiman A, Sofian FF, Santi NMWS, Aulifa DL. The formulation of lozenge using black mulberries (Morus nigra L.) leaf extract as an α-glucosidase inhibitor. J Pharm Bioallied Sci 2020;12:171-6. [PMID: 32742116 DOI: 10.4103/jpbs.JPBS_219_19] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
22 Ullah H, Rahim F, Taha M, Hussain R, Tabassum N, Wadood A, Nawaz M, Mosaddik A, Imran S, Wahab Z, Miana GA, Kanwal, Khan KM. Aryl-oxadiazole Schiff bases: Synthesis, α-glucosidase in vitro inhibitory activity and their in silico studies. Arabian Journal of Chemistry 2020;13:4904-15. [DOI: 10.1016/j.arabjc.2020.01.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
23 Bevan G, De Poli C, Keng MJ, Raine R. How valid are projections of the future prevalence of diabetes? Rapid reviews of prevalence-based and Markov chain models and comparisons of different models' projections for England. BMJ Open 2020;10:e033483. [PMID: 32132137 DOI: 10.1136/bmjopen-2019-033483] [Reference Citation Analysis]
24 Shindo K, Fukuda H, Hitsumoto T, Ito S, Kim J, Washio T, Kitakaze M. Plasma BNP Levels and Diuretics Use as Predictors of Cardiovascular Events in Patients with Myocardial Infarction and Impaired Glucose Tolerance. Cardiovasc Drugs Ther 2020;34:79-88. [PMID: 32076931 DOI: 10.1007/s10557-019-06922-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
25 Kim JD, Lee W. Prevention of Type 2 Diabetes. Cardiovasc Prev Pharmacother 2020;2:63. [DOI: 10.36011/cpp.2020.2.e10] [Reference Citation Analysis]
26 Bae T, Jeon N, Choi S, Seo J. Effect of Nutrition Counseling by Nutrition Care Process on Diet Therapy Practice and Glycemic Control in Type 2 Diabetic Patients. Korean J Community Nutr 2020;25:214. [DOI: 10.5720/kjcn.2020.25.3.214] [Reference Citation Analysis]
27 Coppell K, Freer T, Abel S, Whitehead L, Tipene-Leach D, Gray AR, Merriman T, Sullivan T, Krebs J, Perreault L. What predicts regression from pre-diabetes to normal glucose regulation following a primary care nurse-delivered dietary intervention? A study protocol for a prospective cohort study. BMJ Open 2019;9:e033358. [PMID: 31822546 DOI: 10.1136/bmjopen-2019-033358] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
28 Knowler WC, Crandall JP. Pharmacologic Randomized Clinical Trials in Prevention of Type 2 Diabetes. Curr Diab Rep 2019;19:154. [PMID: 31792721 DOI: 10.1007/s11892-019-1268-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Taha M, Alshamrani FJ, Rahim F, Hayat S, Ullah H, Zaman K, Imran S, Khan KM, Naz F. Synthesis of Novel Triazinoindole-Based Thiourea Hybrid: A Study on α-Glucosidase Inhibitors and Their Molecular Docking. Molecules 2019;24:E3819. [PMID: 31652777 DOI: 10.3390/molecules24213819] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
30 Coleman RL, Scott CAB, Lang Z, Bethel MA, Tuomilehto J, Holman RR. Meta-analysis of the impact of alpha-glucosidase inhibitors on incident diabetes and cardiovascular outcomes. Cardiovasc Diabetol 2019;18:135. [PMID: 31623625 DOI: 10.1186/s12933-019-0933-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
31 Harreiter J, Roden M. [Diabetes mellitus-Definition, classification, diagnosis, screening and prevention (Update 2019)]. Wien Klin Wochenschr 2019;131:6-15. [PMID: 30980151 DOI: 10.1007/s00508-019-1450-4] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 18.0] [Reference Citation Analysis]
32 Wasserman DH, Wang TJ, Brown NJ. The Vasculature in Prediabetes. Circ Res 2018;122:1135-50. [PMID: 29650631 DOI: 10.1161/CIRCRESAHA.118.311912] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 21.3] [Reference Citation Analysis]
33 Khan RMM, Chua ZJY, Tan JC, Yang Y, Liao Z, Zhao Y. From Pre-Diabetes to Diabetes: Diagnosis, Treatments and Translational Research. Medicina (Kaunas). 2019;55. [PMID: 31470636 DOI: 10.3390/medicina55090546] [Cited by in Crossref: 77] [Cited by in F6Publishing: 85] [Article Influence: 25.7] [Reference Citation Analysis]
34 Shubrook JH, Chen W, Lim A. Evidence for the Prevention of Type 2 Diabetes Mellitus. J Am Osteopath Assoc 2018;118:730-7. [PMID: 30398570 DOI: 10.7556/jaoa.2018.158] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
35 Pokrovskaya EV, Shamkhalova MS, Shestakova MV. The new views on the state of the gut microbiota in obesity and diabetes mellitus type 2. Diabetes mellitus 2019;22:253-262. [DOI: 10.14341/dm10194] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
36 Sheng Z, Cao JY, Pang YC, Xu HC, Chen JW, Yuan JH, Wang R, Zhang CS, Wang LX, Dong J. Effects of Lifestyle Modification and Anti-diabetic Medicine on Prediabetes Progress: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne) 2019;10:455. [PMID: 31354627 DOI: 10.3389/fendo.2019.00455] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
37 Yamaoka K, Nemoto A, Tango T. Comparison of the Effectiveness of Lifestyle Modification with Other Treatments on the Incidence of Type 2 Diabetes in People at High Risk: A Network Meta-Analysis. Nutrients 2019;11:E1373. [PMID: 31248094 DOI: 10.3390/nu11061373] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
38 Kohda Y, Matsumura H. Obesity-related hypertension and enhanced plasma orexin-A level are attenuated by the consumption of thiamine water in diabetic rats under cerebral oxidative stress conditions. Fundam Toxicol Sci 2019;6:383-390. [DOI: 10.2131/fts.6.383] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
39 Hanefeld M, Mertes G. Treatment: Alpha Glucosidase Inhibitors. Encyclopedia of Endocrine Diseases 2019. [DOI: 10.1016/b978-0-12-801238-3.65370-9] [Reference Citation Analysis]
40 Moelands SV, Lucassen PL, Akkermans RP, De Grauw WJ, Van de Laar FA. Alpha-glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database Syst Rev 2018;12:CD005061. [PMID: 30592787 DOI: 10.1002/14651858.CD005061.pub3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
41 Fagg J, Valabhji J. How do we identify people at high risk of Type 2 diabetes and help prevent the condition from developing? Diabet Med 2019;36:316-25. [PMID: 30466172 DOI: 10.1111/dme.13867] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
42 Rhee SY, Chon S, Ahn KJ, Woo JT; Korean Diabetes Prevention Study Investigators. Hospital-Based Korean Diabetes Prevention Study: A Prospective, Multi-Center, Randomized, Open-Label Controlled Study. Diabetes Metab J 2019;43:49-58. [PMID: 30398039 DOI: 10.4093/dmj.2018.0033] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
43 Echouffo-Tcheugui JB, Kengne AP, Ali MK. Issues in Defining the Burden of Prediabetes Globally. Curr Diab Rep 2018;18:105. [PMID: 30229351 DOI: 10.1007/s11892-018-1089-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
44 Paudel P, Yu T, Seong SH, Kuk EB, Jung HA, Choi JS. Protein Tyrosine Phosphatase 1B Inhibition and Glucose Uptake Potentials of Mulberrofuran G, Albanol B, and Kuwanon G from Root Bark of Morus alba L. in Insulin-Resistant HepG2 Cells: An In Vitro and In Silico Study. Int J Mol Sci 2018;19:E1542. [PMID: 29786669 DOI: 10.3390/ijms19051542] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 7.5] [Reference Citation Analysis]
45 Bae JH, Kim LK, Min SH, Ahn CH, Cho YM. Postprandial glucose-lowering effect of premeal consumption of protein-enriched, dietary fiber-fortified bar in individuals with type 2 diabetes mellitus or normal glucose tolerance. J Diabetes Investig 2018;9:1110-8. [PMID: 29502350 DOI: 10.1111/jdi.12831] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
46 Haneda M, Noda M, Origasa H, Noto H, Yabe D, Fujita Y, Goto A, Kondo T, Araki E. Japanese Clinical Practice Guideline for Diabetes 2016. Diabetol Int 2018;9:1-45. [PMID: 30603347 DOI: 10.1007/s13340-018-0345-3] [Cited by in Crossref: 126] [Cited by in F6Publishing: 105] [Article Influence: 31.5] [Reference Citation Analysis]
47 Haneda M, Noda M, Origasa H, Noto H, Yabe D, Fujita Y, Goto A, Kondo T, Araki E. Japanese Clinical Practice Guideline for Diabetes 2016. J Diabetes Investig 2018. [PMID: 29582574 DOI: 10.1111/jdi.12810] [Cited by in Crossref: 137] [Cited by in F6Publishing: 144] [Article Influence: 34.3] [Reference Citation Analysis]
48 Knowler WC. Prevention of Type 2 Diabetes. Endocrinology 2018. [DOI: 10.1007/978-3-319-27317-4_16-1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
49 Joung H, Kwon H. Pharmacological Intervention for the Prevention of Diabetes Mellitus. J Korean Diabetes 2018;19:140. [DOI: 10.4093/jkd.2018.19.3.140] [Reference Citation Analysis]
50 Knowler WC. Prevention of Type 2 Diabetes. Endocrinology 2018. [DOI: 10.1007/978-3-319-45015-5_16] [Reference Citation Analysis]
51 Haw JS, Galaviz KI, Straus AN, Kowalski AJ, Magee MJ, Weber MB, Wei J, Narayan KMV, Ali MK. Long-term Sustainability of Diabetes Prevention Approaches: A Systematic Review and Meta-analysis of Randomized Clinical Trials. JAMA Intern Med 2017;177:1808-17. [PMID: 29114778 DOI: 10.1001/jamainternmed.2017.6040] [Cited by in Crossref: 167] [Cited by in F6Publishing: 173] [Article Influence: 33.4] [Reference Citation Analysis]
52 Pal DK, Bhalla A, Bammidi S, Telles S, Kohli A, Kumar S, Devi P, Kaur N, Sharma K, Kumar R, Malik N, Thakur V, Bhargava GG, Goyal AK, Devi G, Chauhan S, Singh G, Ahmad S, Joshi M, Narwal S, Sharma K, Tyagi R, Modgil S, Bali P, Bhatt V, Sharma J, Singh A, Negi J, Rajesh SK, Sharma G, Sharma P, Vats R, Nagarathna R, Bhavanani AB, Burugupalli KM, Vetrivendan R, Nagendra H, Anand A. Can Yoga-Based Diabetes Management Studies Facilitate Integrative Medicine in India Current Status and Future Directions. Integr Med Int 2019;4:125-41. [DOI: 10.1159/000479816] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
53 Luthra T, Agarwal R, Estari M, Adepally U, Sen S. A novel library of -arylketones as potential inhibitors of α-glucosidase: Their design, synthesis, in vitro and in vivo studies. Sci Rep 2017;7:13246. [PMID: 29038580 DOI: 10.1038/s41598-017-13798-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
54 Herman WH. The global agenda for the prevention of type 2 diabetes. Nutr Rev 2017;75:13-8. [PMID: 28049746 DOI: 10.1093/nutrit/nuw034] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
55 Hao L, Schlussel Y, Fieselmann K, Schneider SH, Shapses SA. Appetite and Gut Hormones Response to a Putative α-Glucosidase Inhibitor, Salacia Chinensis, in Overweight/Obese Adults: A Double Blind Randomized Controlled Trial. Nutrients 2017;9:E869. [PMID: 28805670 DOI: 10.3390/nu9080869] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
56 Aroda VR, Knowler WC, Crandall JP, Perreault L, Edelstein SL, Jeffries SL, Molitch ME, Pi-Sunyer X, Darwin C, Heckman-Stoddard BM, Temprosa M, Kahn SE, Nathan DM; Diabetes Prevention Program Research Group. Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study. Diabetologia 2017;60:1601-11. [PMID: 28770322 DOI: 10.1007/s00125-017-4361-9] [Cited by in Crossref: 88] [Cited by in F6Publishing: 94] [Article Influence: 17.6] [Reference Citation Analysis]
57 Avgerinos K, Tziomalos K. Effects of glucose-lowering agents on ischemic stroke. World J Diabetes 2017; 8(6): 270-277 [PMID: 28694927 DOI: 10.4239/wjd.v8.i6.270] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
58 Shi YL, Liu WJ, Zhang XF, Su WJ, Chen NN, Lu SH, Wang LY, Shi XL, Li ZB, Yang SY. Effect of Chinese Herbal Medicine Jinlida Granule in Treatment of Patients with Impaired Glucose Tolerance. Chin Med J (Engl) 2016;129:2281-6. [PMID: 27647185 DOI: 10.4103/0366-6999.190676] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
59 Chen X, Lu Y, Fan Y, Shen Y. Voglibose. Validamycin and its Derivatives 2017. [DOI: 10.1016/b978-0-08-100999-4.00005-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
60 He T, Geng J, Zhang Z. Diabetics and Stroke. Translational Medicine Research 2017. [DOI: 10.1007/978-981-10-5804-2_9] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
61 Bray GA. Obesity and the Risk for Type 2 Diabetes. Nutrition in the Prevention and Treatment of Disease 2017. [DOI: 10.1016/b978-0-12-802928-2.00030-8] [Reference Citation Analysis]
62 Chan JCN, Chow EYK, Luk AO. Diabetes in China and the Western Pacific Region. Diabetes Mellitus in Developing Countries and Underserved Communities 2017. [DOI: 10.1007/978-3-319-41559-8_5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
63 Ugi S, Maegawa H, Morino K, Nishio Y, Sato T, Okada S, Kikkawa Y, Watanabe T, Nakajima H, Kashiwagi A. Evaluation of a Novel Glucose Area Under the Curve (AUC) Monitoring System: Comparison with the AUC by Continuous Glucose Monitoring. Diabetes Metab J 2016;40:326-33. [PMID: 27535643 DOI: 10.4093/dmj.2016.40.4.326] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
64 Kawahara T, Suzuki G, Inazu T, Mizuno S, Kasagi F, Okada Y, Tanaka Y. Rationale and design of Diabetes Prevention with active Vitamin D (DPVD): a randomised, double-blind, placebo-controlled study. BMJ Open 2016;6:e011183. [PMID: 27388357 DOI: 10.1136/bmjopen-2016-011183] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
65 Iwahashi H, Imagawa A. Type 2 diabetes mellitus prevention strategy: Target and goal in Japanese men. J Diabetes Investig 2016;7:283-5. [PMID: 27330711 DOI: 10.1111/jdi.12481] [Reference Citation Analysis]
66 Sun S, Kadouh HC, Zhu W, Zhou K. Bioactivity-guided isolation and purification of α-glucosidase inhibitor, 6-O-D-glycosides, from Tinta Cão grape pomace. J Funct Foods 2016;23:573-9. [PMID: 30381790 DOI: 10.1016/j.jff.2016.03.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
67 Numao S. A single bout of exercise and postprandial hyperglycemia caused by high-fat diet. JPFSM 2016;5:181-185. [DOI: 10.7600/jpfsm.5.181] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
68 Lown M, Fuller R, Lightowler H, Fraser A, Gallagher A, Stuart B, Byrne CD, Lewith G. Mulberry extract to modULate Blood glucosE Responses in noRmoglYcaemic adults (MULBERRY): study protocol for a randomised controlled trial. Trials 2015;16:486. [PMID: 26511964 DOI: 10.1186/s13063-015-0997-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
69 Basavareddy A, Dass AS, Narayana S. Prediabetes Awareness and Practice Among Indian Doctors- A Cross-sectional Study. J Clin Diagn Res 2015;9:FC01-3. [PMID: 26435963 DOI: 10.7860/JCDR/2015/13391.6290] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
70 Kanat M, DeFronzo RA, Abdul-Ghani MA. Treatment of prediabetes. World J Diabetes 2015; 6(12): 1207-1222 [PMID: 26464759 DOI: 10.4239/wjd.v6.i12.1207] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 46] [Article Influence: 6.3] [Reference Citation Analysis]
71 Yoshikawa R, Hishinuma R, Kaneko H, Yanai H. Agranulocytosis due to an α-glucosidase inhibitor, voglibose. Int J Diabetes Dev Ctries 2015;35:384-385. [DOI: 10.1007/s13410-014-0242-7] [Reference Citation Analysis]
72 Kaku K, Kadowaki T, Terauchi Y, Okamoto T, Sato A, Okuyama K, Arjona Ferreira JC, Goldstein BJ. Sitagliptin improves glycaemic excursion after a meal or after an oral glucose load in Japanese subjects with impaired glucose tolerance. Diabetes Obes Metab 2015;17:1033-41. [PMID: 26094974 DOI: 10.1111/dom.12507] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
73 Aroda VR, Getaneh A. Guiding diabetes screening and prevention: rationale, recommendations and remaining challenges. Expert Rev Endocrinol Metab 2015;10:381-98. [PMID: 30293496 DOI: 10.1586/17446651.2015.1054280] [Reference Citation Analysis]
74 Srinivasan S, Florez JC. Therapeutic Challenges in Diabetes Prevention: We Have Not Found the "Exercise Pill". Clin Pharmacol Ther 2015;98:162-9. [PMID: 25974616 DOI: 10.1002/cpt.146] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
75 Bansal N. Prediabetes diagnosis and treatment: A review. World J Diabetes 2015; 6(2): 296-303 [PMID: 25789110 DOI: 10.4239/wjd.v6.i2.296] [Cited by in CrossRef: 243] [Cited by in F6Publishing: 258] [Article Influence: 34.7] [Reference Citation Analysis]
76 Saisho Y. β-cell dysfunction: Its critical role in prevention and management of type 2 diabetes. World J Diabetes 2015; 6(1): 109-124 [PMID: 25685282 DOI: 10.4239/wjd.v6.i1.109] [Cited by in CrossRef: 120] [Cited by in F6Publishing: 126] [Article Influence: 17.1] [Reference Citation Analysis]
77 Numao S. Role of Physical Exercise on Postprandial Blood Glucose Responses to Low-Carbohydrate/High-Fat Diet Intake. Physical Activity, Exercise, Sedentary Behavior and Health 2015. [DOI: 10.1007/978-4-431-55333-5_13] [Reference Citation Analysis]
78 Jeon JY, Kim DJ. Need for Diabetes Prevention Study. J Korean Diabetes 2015;16:161. [DOI: 10.4093/jkd.2015.16.3.161] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
79 Yokoh H, Kobayashi K, Sato Y, Takemoto M, Uchida D, Kanatsuka A, Kuribayashi N, Terano T, Hashimoto N, Sakurai K. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin compared with alpha-glucosidase inhibitor in Japanese patients with type 2 diabetes inadequately controlled on metformin or pioglitazone alone (Study for an Ultimate Combination Therapy to Control Diabetes with Sitagliptin-1): A multicenter, randomized, open-label, non-inferiority trial. J Diabetes Investig. 2015;6:182-191. [PMID: 25802726 DOI: 10.1111/jdi.12282] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
80 Wu Y, Ding Y, Tanaka Y, Zhang W. Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention. Int J Med Sci. 2014;11:1185-1200. [PMID: 25249787 DOI: 10.7150/ijms.10001] [Cited by in Crossref: 458] [Cited by in F6Publishing: 492] [Article Influence: 57.3] [Reference Citation Analysis]
81 Saisho Y. Importance of Beta Cell Function for the Treatment of Type 2 Diabetes. J Clin Med 2014;3:923-43. [PMID: 26237486 DOI: 10.3390/jcm3030923] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 4.1] [Reference Citation Analysis]
82 Ikeda S, Kobayashi M, Tajima N. Cost-effectiveness analysis of voglibose for prevention of type 2 diabetes mellitus in Japanese patients with impaired glucose tolerance. J Diabetes Investig 2010;1:252-8. [PMID: 24843440 DOI: 10.1111/j.2040-1124.2010.00052.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
83 Asai A, Nakagawa K, Higuchi O, Kimura T, Kojima Y, Kariya J, Miyazawa T, Oikawa S. Effect of mulberry leaf extract with enriched 1-deoxynojirimycin content on postprandial glycemic control in subjects with impaired glucose metabolism. J Diabetes Investig 2011;2:318-23. [PMID: 24843505 DOI: 10.1111/j.2040-1124.2011.00101.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 67] [Article Influence: 8.3] [Reference Citation Analysis]
84 Yu X, Chen P, Wang H, Jin H, Jia W, Wang L. Clinical study of exercise on improvement of β-cell function and insulin resistance in non-diabetic young offsprings of diabetic patients. J Endocrinol Invest 2014;37:353-8. [PMID: 24682911 DOI: 10.1007/s40618-013-0033-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
85 Schulze MB, Hu FB. Epidemiology of Diabetes. Handbook of Epidemiology 2014. [DOI: 10.1007/978-0-387-09834-0_66] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
86 Kaku K. 8. Progress in Treatment of Diabetes. J Jpn Soc Intern Med 2014;103:2275-2281. [DOI: 10.2169/naika.103.2275] [Reference Citation Analysis]
87 Defronzo RA, Tripathy D, Schwenke DC, Banerji M, Bray GA, Buchanan TA, Clement SC, Henry RR, Kitabchi AE, Mudaliar S. Prediction of diabetes based on baseline metabolic characteristics in individuals at high risk. Diabetes Care. 2013;36:3607-3612. [PMID: 24062330 DOI: 10.2337/dc13-0520] [Cited by in Crossref: 41] [Cited by in F6Publishing: 47] [Article Influence: 4.6] [Reference Citation Analysis]
88 Khavandi K, Amer H, Ibrahim B, Brownrigg J. Strategies for preventing type 2 diabetes: an update for clinicians. Ther Adv Chronic Dis. 2013;4:242-261. [PMID: 23997928 DOI: 10.1177/2040622313494986] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
89 Okauchi Y, Iwahashi H, Okita K, Funahashi T, Kishida K, Noguchi M, Ohira T, Nakamura T, Imagawa A, Shimomura I. Weight reduction is associated with improvement of glycemic control in Japanese men, whose hemoglobin A1C is 5.6-6.4%, with visceral fat accumulation, but not without visceral fat accumulation. J Diabetes Investig 2013;4:454-9. [PMID: 24843695 DOI: 10.1111/jdi.12084] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
90 Kabadi UM. Comparative efficacy between glimepiride and metformin in preventing progression of prediabetes to type 2 diabetes. JDM 2013;03:129-133. [DOI: 10.4236/jdm.2013.33019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
91 Jang K, Cho S, Kim J, Chung J, Lim KS, Jang I, Yu K. A Placebo-Controlled, Single and Multiple Dose Study to Investigate the Appropriate Parameters for Evaluation of Pharmacodynamic Equivalence of Voglibose in Healthy Korean Volunteers. J Korean Soc Clin Pharmacol Ther 2013;21:63. [DOI: 10.12793/jkscpt.2013.21.1.63] [Reference Citation Analysis]
92 Urabe T. Diabetes mellitus in ischemic stroke patients. Jpn J Stroke 2013;35:103-107. [DOI: 10.3995/jstroke.35.103] [Reference Citation Analysis]
93 Olokoba AB, Obateru OA, Olokoba LB. Type 2 diabetes mellitus: a review of current trends. Oman Med J. 2012;27:269-273. [PMID: 23071876 DOI: 10.5001/omj.2012.68] [Cited by in Crossref: 545] [Cited by in F6Publishing: 585] [Article Influence: 54.5] [Reference Citation Analysis]
94 Choudhary N, Kalra S, Unnikrishnan AG, Ajish TP. Preventive pharmacotherapy in type 2 diabetes mellitus. Indian J Endocrinol Metab 2012;16:33-43. [PMID: 22276251 DOI: 10.4103/2230-8210.91183] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
95 Ohta T, Miyajima K, Shinohara M, Yamamoto T, Yamada T. Inhibition of Postprandial Hyperglycemia Prevents the Incidence of Diabetes in Spontaneously Diabetic Torii (SDT) Rats. J of Animal and Veterinary Advances 2012;11:1583-1587. [DOI: 10.3923/javaa.2012.1583.1587] [Reference Citation Analysis]
96 Hsu WC, Boyko EJ, Fujimoto WY, Kanaya A, Karmally W, Karter A, King GL, Look M, Maskarinec G, Misra R. Pathophysiologic differences among Asians, native Hawaiians, and other Pacific Islanders and treatment implications. Diabetes Care. 2012;35:1189-1198. [PMID: 22517940 DOI: 10.2337/dc12-0212] [Cited by in Crossref: 47] [Cited by in F6Publishing: 53] [Article Influence: 4.7] [Reference Citation Analysis]
97 Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. Prediabetes: a high-risk state for diabetes development. Lancet. 2012;379:2279-2290. [PMID: 22683128 DOI: 10.1016/s0140-6736(12)60283-9] [Cited by in Crossref: 1388] [Cited by in F6Publishing: 1478] [Article Influence: 138.8] [Reference Citation Analysis]
98 Matusheski NV, Bidel S, Tuomilehto J. Coffee and Type 2 Diabetes Risk. In: Chu Y, editor. Coffee. Oxford: Wiley-Blackwell; 2012. pp. 141-79. [DOI: 10.1002/9781119949893.ch8] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
99 Karam JG, Mcfarlane SI. Prevention of Type 2 Diabetes: Evidence from Clinical Trials. Diabetes and Hypertension 2012. [DOI: 10.1007/978-1-60327-357-2_12] [Reference Citation Analysis]
100 Kalra S, Malik S, John M. Gestational diabetes mellitus: A window of opportunity. Indian J Endocrinol Metab 2011;15:149-51. [PMID: 21897889 DOI: 10.4103/2230-8210.83395] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
101 DeFronzo RA, Abdul-Ghani M. Type 2 diabetes can be prevented with early pharmacological intervention. Diabetes Care 2011;34 Suppl 2:S202-9. [PMID: 21525456 DOI: 10.2337/dc11-s221] [Cited by in Crossref: 94] [Cited by in F6Publishing: 102] [Article Influence: 8.5] [Reference Citation Analysis]
102 Kempf K, Martin S. Pathophysiologie und Prävention des Typ-2-Diabetes. Diabetologe 2011;7:161-169. [DOI: 10.1007/s11428-011-0685-0] [Reference Citation Analysis]
103 American Diabetes Association. Standards of medical care in diabetes--2011. Diabetes Care. 2011;34 Suppl 1:S11-S61. [PMID: 21193625 DOI: 10.2337/dc11-s011] [Cited by in Crossref: 1811] [Cited by in F6Publishing: 2033] [Article Influence: 164.6] [Reference Citation Analysis]
104 Gore MO, Inzucchi SE, Mcguire DK. Diabetes and Cardiovascular Disease. Preventive Cardiology: Companion to Braunwald's Heart Disease 2011. [DOI: 10.1016/b978-1-4377-1366-4.00021-4] [Reference Citation Analysis]
105 Kawamori R. A commentary on the “consensus statement” regarding the use of BIAsp30. Journal of Diabetes Investigation 2010;1:101-102. [DOI: 10.1111/j.2040-1124.2010.00017.x] [Reference Citation Analysis]
106 American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care. 2010;33 Suppl 1:S11-S61. [PMID: 20042772 DOI: 10.2337/dc10-s011] [Cited by in Crossref: 2086] [Cited by in F6Publishing: 2353] [Article Influence: 173.8] [Reference Citation Analysis]
107 Deguchi Y, Miyazaki K. Anti-hyperglycemic and anti-hyperlipidemic effects of guava leaf extract. Nutr Metab (Lond) 2010;7:9. [PMID: 20181067 DOI: 10.1186/1743-7075-7-9] [Cited by in Crossref: 84] [Cited by in F6Publishing: 86] [Article Influence: 7.0] [Reference Citation Analysis]
108 Kawamori R. Sportology for the Prevention and Treatment of Diabetes Mellitus. Juntendo Medical Journal 2010;56:239-242. [DOI: 10.14789/pjmj.56.239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
109 Mühlhauser I. Voglibose for prevention of type 2 diabetes mellitus. The Lancet 2009;374:448. [DOI: 10.1016/s0140-6736(09)61445-8] [Reference Citation Analysis]
110 Shen L, Sun X, Yao L. Voglibose for prevention of type 2 diabetes mellitus. The Lancet 2009;374:448-449. [DOI: 10.1016/s0140-6736(09)61446-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
111 Fisman EZ, Tenenbaum A. A cardiologic approach to non-insulin antidiabetic pharmacotherapy in patients with heart disease. Cardiovasc Diabetol 2009;8:38. [PMID: 19619327 DOI: 10.1186/1475-2840-8-38] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis]